GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (OSTO:BOUL) » Definitions » Gross Profit

Boule Diagnostics AB (OSTO:BOUL) Gross Profit : kr254.4 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Boule Diagnostics AB Gross Profit?

Boule Diagnostics AB's gross profit for the three months ended in Sep. 2024 was kr61.1 Mil. Boule Diagnostics AB's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was kr254.4 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Boule Diagnostics AB's gross profit for the three months ended in Sep. 2024 was kr61.1 Mil. Boule Diagnostics AB's Revenue for the three months ended in Sep. 2024 was kr130.5 Mil. Therefore, Boule Diagnostics AB's Gross Margin % for the quarter that ended in Sep. 2024 was 46.82%.

Boule Diagnostics AB had a gross margin of 46.82% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Boule Diagnostics AB was 48.06%. The lowest was 41.58%. And the median was 44.60%.

Warning Sign:

Boule Diagnostics AB gross margin has been in long-term decline. The average rate of decline per year is -1.2%.


Boule Diagnostics AB Gross Profit Historical Data

The historical data trend for Boule Diagnostics AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB Gross Profit Chart

Boule Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 226.21 177.19 198.64 227.91 249.71

Boule Diagnostics AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.90 65.91 68.40 59.00 61.10

Competitive Comparison of Boule Diagnostics AB's Gross Profit

For the Medical Devices subindustry, Boule Diagnostics AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's Gross Profit falls into.



Boule Diagnostics AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Boule Diagnostics AB's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=571.329 - 321.615
=249.7

Boule Diagnostics AB's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=130.5 - 69.4
=61.1

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr254.4 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Boule Diagnostics AB's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=61.1 / 130.5
=46.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Boule Diagnostics AB  (OSTO:BOUL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Boule Diagnostics AB had a gross margin of 46.82% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Boule Diagnostics AB Gross Profit Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB Business Description

Traded in Other Exchanges
N/A
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB Headlines

No Headlines